Sandhiya V , Sandhiya , Praveen Kumar M , Prasanth Ra C N , Nirmal P! , Mano A# , Suhai$ I&
Sandhiya V, Praeen KumarM, Prasanth Raj C N, et al. Conentional Vs Transdermal Drug Deliery System. RFP Journal of
Dermatology2022&(1)
ABS RAC
Manymedicationsarenowadministeredorally&howeertheyarenotaseffectieas
theyshould e.Beyondthelocalapplicationsite,transdermaldelierytechnology
is eing e*ploredtotreatawide range ofdiseases.Becauseof reducedfirstpass
meta olism,aoidanceofanadersegastrointestinalenironment,andthepotential
toproidee*tendedandregulateddrugdeliery,transdermaldrugadministration
offerssu stantial enefitsoeroraltreatment.Transdermaldrugdelierysystems
(TDDS)aretopically appliedpatchesthatreleasemedicationsfor systemiceffects
atapredeterminedandregulatedrate.Itworks yputting amedicationinsidea
patchandwearingitforalongtimeontheskin.Asaresult,asteadyconcentration
ofmedication remains inthe loodstreamfor an e*tendedperiod oftime. TDDS
products include Scopolamine, Nicotine, Testosterone, Fentanyl, and Clonidine.
Numerousactiecompoundswitharia lemolecularsi3eandstructurecannot e
maintainedintransdermalform,despitetheirmany enefits.
Key(ords)Transdermalpatch,Skin,Permeationpathways,Matri*.
No records found.
Monday 26 January 2026, 18:55:47 (IST)
Download citation
Highlight selected keywords in the article text.
| Received | N/A |
| Accepted | N/A |
| Published | N/A |